Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics. Researchers at UC San Francisco and the Gladstone Institutes have developed new ...

Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and ...

Worm infections stir up inflammation, keeping the immune system in a constant state of ...

Dozens of trials on HIV ground to a halt in February after US President Donald Trump abruptly pulled crucial funding.

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

AIDS advocacy group ACT UP Cleveland meets to discuss plans to stockpile antiviral medications ahead of proposed federal cuts ...

If the human immunodeficiency virus is less well suppressed thanks to President Trump’s cuts to USAID, it risks finding more ...

Viral proteases have often been the target of attempts to make antiviral drugs, most notably for HIV. Shoichet’s molecular ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...